Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tromantadine is an antiviral small molecule of the adamantane derivative class used primarily as a topical gel for the treatment of herpes simplex virus infections and herpes zoster (shingles)[1][2][3][4]. It is marketed under brand names such as Viru-Merz and Viru-Merz Serol[4]. Tromantadine acts by inhibiting both early and late stages of viral replication. Its mechanism involves altering host cell glycoproteins to impede viral absorption, inhibiting penetration of the virus into cells, and preventing uncoating of virions[1][2][4][5]. The drug’s performance in clinical use is similar to aciclovir[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tromantadine.